Different Approaches to Maternal Hypotension During Cesarean Section

Sponsor
University of Parma (Other)
Overall Status
Completed
CT.gov ID
NCT00991627
Collaborator
Azienda Ospedaliero-Universitaria di Parma (Other)
36
1
2
11
3.3

Study Details

Study Description

Brief Summary

The aim of this study is to compare two different therapeutic approaches to blood pressure reduction: pharmacological vs. non-pharmacological. The setting is that of patients undergoing scheduled Cesarean section under spinal anesthesia and suffering from aorta-caval compression syndrome, which causes a sudden drop in blood pressure.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

The supine hypotensive syndrome of pregnancy is induced by compression of the inferior caval vein by the enlarged uterus. It occurs in approximately 8% of pregnant women at term. More patients may develop an asymptomatic variety of this syndrome in the supine position. The hypotensive effect of spinal anesthesia per se may thus be aggravated in a significant number of term parturients. A preoperative supine stress test (SST) before elective cesarean section under spinal anesthesia has been shown to predict severe systolic hypotension with reasonable accuracy.

Different strategies have been proposed for the management of this complication; they can be divided into pharmacological and non-pharmacological ones.

According to pharmacological strategies, vasoactive drugs are used to treat hypotension induced by sympathetic efferent blockade following spinal anesthesia. To this end, α-agonist ephedrine is commonly considered the best choice because of its minimal impact on the fetoplacental circulation. However, excessive use of ephedrine may be detrimental to neonatal well-being because of its vasoconstrictor effect on fetoplacental circulation.

Non-pharmacological treatments may represent a valuable, safer alternative. According to many authors non-pharmacological treatments aimed at removing the cause of aorta-caval compression syndrome are to be preferred because more appropriate from an etiopathogenetic point of view. The use of a wedge-shaped cushion placed under the right hip is a well-known non-pharmacological strategy which allows the uterine left lateral displacement and, consequently, the removing of the compression from the inferior vena cava.

The aim of the present study is to compare, through the evaluation of neonatal well-being, the efficacy of these approaches to hypotension after spinal anesthesia for elective Caesarean section in parturients affected by aorto-caval compression.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pharmacological or Non-Pharmacological Management of Maternal Hypotension During Elective Cesarean Section Under Subarachnoid Anesthesia: a Randomized, Controlled Trial
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Aug 1, 2010
Actual Study Completion Date :
Aug 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Pharmacological

Patients in this group will receive a basal infusion of ephedrine. Hypotension will be treated for a reduction in systolic blood pressure 20% below baseline values.

Drug: Bupivacaine
10 mg of a 5 mg/ml hyperbaric solution, intrathecally
Other Names:
  • Marcain
  • Local Anesthetic
  • Drug: Morphine
    200 µg of a 100 µg/ml solution, intrathecally
    Other Names:
  • Intrathecal morphine
  • Drug: Lactated Ringer's solution
    25 ml/min intravenously

    Drug: Ephedrine, continuous infusion
    37.5 mg/h intravenously

    Drug: Ephedrine, bolus
    6.25 mg IV bolus prn. Hypotension defined according to study protocol for each arm.

    Drug: Atropine
    0.1 mg/kg iv bolus prn Bradycardia defined as 50% drop in heart rate from baseline values.

    Experimental: Non-Pharmacological

    Patients in this group will undergo uterine lateral displacement through the use of a wedge-shaped cushion placed under their right hip. Hypotension will be treated for a reduction in systolic blood pressure 40% below baseline values.

    Drug: Bupivacaine
    10 mg of a 5 mg/ml hyperbaric solution, intrathecally
    Other Names:
  • Marcain
  • Local Anesthetic
  • Drug: Morphine
    200 µg of a 100 µg/ml solution, intrathecally
    Other Names:
  • Intrathecal morphine
  • Drug: Lactated Ringer's solution
    25 ml/min intravenously

    Drug: Ephedrine, bolus
    6.25 mg IV bolus prn. Hypotension defined according to study protocol for each arm.

    Drug: Atropine
    0.1 mg/kg iv bolus prn Bradycardia defined as 50% drop in heart rate from baseline values.

    Outcome Measures

    Primary Outcome Measures

    1. Neonatal arterial base excess [<5 min from birth]

    Secondary Outcome Measures

    1. Neonatal arterial and venous pH, venous base excess [<5 min from birth]

    2. Apgar score [1 and 5 minutes from birth]

    3. Maternal serum levels of cardiac troponin (baseline, immediate postsurgery, 6 and 12 hours after surgery) [Baseline and up to 12 h postoperatively]

    4. Incidence of maternal hypotension ( <20% baseline or mean arterial pressure <60 mmHg). [q5min from anesthesia to end of surgery]

    5. Incidence of maternal bradycardia (heart rate <30% of baseline or <60 beats per minute) [q5min from anesthesia to end of surgery]

    6. Peripheral arterial oxygen saturation: incidence of desaturation (SpO2 <92%) and mean values for each arm. [q5min from anesthesia to end of surgery]

    7. Administered atropine [from anesthesia to end of surgery]

    8. Amount of ephedrine administered (mg) [from anesthesia to end of surgery]

    9. Time between induction of anesthesia and skin incision []

    10. Time between skin incision and delivery []

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients undergoing spinal anesthesia for elective Cesarean section

    • Patients in ASA Physical Status Class I or II

    • Informed written consent to participation

    • Positive Supine Stress Test

    Exclusion Criteria:
    • Any known fetal pathology

    • Indication to general anesthesia

    • Known allergy to any of the study drugs

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University and Hospital of Parma (Azienda Ospedaliero-Universitaria di Parma) Parma PR Italy 43126

    Sponsors and Collaborators

    • University of Parma
    • Azienda Ospedaliero-Universitaria di Parma

    Investigators

    • Study Chair: Guido Fanelli, MD, Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy
    • Study Director: Andrea Cornini, MD, UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma
    • Principal Investigator: Michele Zasa, MD, Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00991627
    Other Study ID Numbers:
    • ANEST-OST-02
    First Posted:
    Oct 8, 2009
    Last Update Posted:
    Aug 27, 2010
    Last Verified:
    Aug 1, 2010

    Study Results

    No Results Posted as of Aug 27, 2010